首页> 外文期刊>American journal of otolaryngology >Craniocervical necrotizing fasciitis with and without thoracic extension: management strategies and outcome.
【24h】

Craniocervical necrotizing fasciitis with and without thoracic extension: management strategies and outcome.

机译:伴或不伴胸廓扩张的颅颈坏死性筋膜炎:治疗策略和预后。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: First objective was to review cases of craniocervical necrotizing fasciitis (CCNF) at Wayne State University/Detroit Medical Center (Detroit, MI) for the last 18 years. Second was to analyze patients with and without thoracic extension for contributing factors. METHODS: Retrospective review of 660 patients with necrotizing fasciitis treated at WSU/DMC from January 1989 to January 2007 was conducted. Data regarding source/extent of infection, presenting signs/symptoms, computed tomography, microbiology, antibiotics, comorbidities, number/type of operations, hyperbaric oxygen (HBO) therapy, hospital duration, complications, and overall outcome were compared/analyzed between patients with and without thoracic extension. RESULTS: Twenty patients with CCNF for the past 18 years met the inclusion criteria. Ten patients had thoracic extension, and 10 patients did not have. Individuals in the thoracic extension group were likely to be older, had increased comorbidity, required more surgical debridement, experienced increased postoperative complications, and had lower overall survival. Three patients with thoracic extension underwent HBO therapy and 66% survived. CONCLUSION: This is the largest single institutional review of CCNF comparing patients with and without thoracic extension. Patients with thoracic extension have a poorer outcome as follows: 60% (6/10) survival vs 100% (10/10) for those without thoracic extension (P < .05). The CCNF patients without thoracic extension treated at our institution all survived after prompt medical and surgical intervention. Overall survival of CCNF patients without thoracic extension may be attributed to rigorous wound care, broad spectrum intravenous antibiotics, aggressive surgical debridement, and vigilant care in surgical intensive care unit. The HBO therapy should be included if the patient can tolerate it.
机译:目的:首要目的是回顾过去18年间在韦恩州立大学/底特律医学中心(密歇根州底特律)的颅颈坏死性筋膜炎(CCNF)病例。其次是分析有或没有胸廓扩张的患者的影响因素。方法:回顾性分析了1989年1月至2007年1月在WSU / DMC治疗的660例坏死性筋膜炎患者。比较/分析了有关感染源/程度,出现体征/症状,计算机断层扫描,微生物学,抗生素,合并症,手术次数/类型,高压氧(HBO)治疗,住院时间,并发症和总体结果的数据。并且没有胸廓延伸。结果:在过去的18年中,有20名CCNF患者符合纳入标准。 10例患者有胸廓扩张,而10例患者则没有。胸廓扩张组的个体可能年龄较大,合并症增加,需要更多的手术清创术,术后并发症增加,总生存期降低。 3例胸廓扩张患者接受了HBO治疗,其中66%存活。结论:这是CCNF比较有或没有胸廓扩张患者的最大的单一机构评价。胸廓扩张患者的预后较差:60%(6/10)生存,而无胸廓扩张的患者为10​​0%(10/10)(P <.05)。在我们机构接受治疗的没有胸廓扩张的CCNF患者在及时的医学和外科手术干预后均存活。没有胸廓伸展的CCNF患者的总体存活率可归因于严格的伤口护理,广谱静脉内抗生素治疗,积极的外科清创术和外科重症监护室的警惕护理。如果患者可以耐受,则应包括HBO治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号